 |
|
|
| |
Hepatitis B surface antigen loss rate and safety and discontinuations with pegylated interferon alpha in chronic hepatitis B virus infection, a systematic review
|
| |
| |
EASL 2023 June 21-24 Vienna>
Vera Gielen1, Amandeep Kaur2, Krishna Kumar2, Saifuddin Kharawala2, Joyeta Das1, Jacob Vincent1, Anadi Mahajan2>
GSK, Brentford, Middlesex, UK; 2Bridge Medical Consulting, London, UK
|
| |
|
|
|
|
|
